Do doctors have a responsibility to help patients import medicines from abroad?
Share this article
Click the icon of the social media platform on which you would like to share this article.
Email this article to a friend
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Other content recommended for you
- Off-label use of bevacizumab in the treatment of retinal disease: ethical implications
- Why have UK doctors been deterred from prescribing Avastin?
- Implications of “not me” drugs for health systems: lessons from age related macular degeneration
- Plasma levels of vascular endothelial growth factor before and after intravitreal injection of bevacizumab, ranibizumab and pegaptanib in patients with age-related macular degeneration, and in patients with diabetic macular oedema
- Bevacizumab for neovascular age related macular degeneration (ABC Trial): multicentre randomised double masked study
- Cluster endophthalmitis due to Stenotrophomonas maltophilia following intravitreal bevacizumab: outcomes of patients from North India
- Are the odds shifting against pharma in the fight for cheaper treatment for macular degeneration?
- Brolucizumab: the road ahead
- Why using Avastin for eye disease is so difficult
- Vascular endothelial growth factor inhibition in uveitis: a systematic review